Cargando…
Getting by with a little help from the right CD4(+) T cells
Tumor infiltration by effector cells is essential for the efficacy of T cell-based immunotherapeutic approaches against brain malignancies. We found that tumor-associated antigen (TAA)-specific CD8(+) T cells are optimally recruited to neoplastic lesions when co-administered with T(H)1 polarized CD4...
Autores principales: | Hoepner, Sabine, Walker, Paul R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825730/ https://www.ncbi.nlm.nih.gov/pubmed/24244904 http://dx.doi.org/10.4161/onci.25772 |
Ejemplares similares
-
Bioreactors get personal
por: Somerville, Robert P.T., et al.
Publicado: (2012) -
Mimotope vaccine efficacy gets a "boost" from native tumor antigens
por: Buhrman, Jonathan D., et al.
Publicado: (2013) -
ERBB2 oncogenicity: ERBIN helps to perform the job
por: Mei, Lin, et al.
Publicado: (2015) -
Long peptide-based cancer immunotherapy targeting tumor antigen-specific CD4(+) and CD8(+) T cells
por: Tomita, Yusuke, et al.
Publicado: (2013) -
Specificity may be overrated in cancer immunotherapy: Getting to know the nonspecific side of memory T Cells
por: Sckisel, Gail D., et al.
Publicado: (2012)